Signaling Pathways - Immunological Diseases - Type 2 Diabetes - Kidney Injury Studies - Psoriasis
清除全部
-
B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂 -
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4抑制剂 -
B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂 -
B6766 CL 316243 disodium saltSummary: 鼠选择性的β3肾上腺素受体激动剂 -
B1410 Amlodipine中文名: 氨氯地平Target: Voltage-gated Calcium Channels (CaV)Summary: 钙通道阻滞剂 -
B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂 -
B1483 Fenoldopam中文名: 非诺多泮Target: D1 and D5 ReceptorsSummary: D1样多巴胺受体部分激动剂 -
B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂 -
B2194 Tolbutamide中文名: 甲苯磺丁脲Target: cAMP|Sulfonylurea receptorsSummary: 第一代钾通道阻滞剂 -
B2236 Desvenlafaxine中文名: 去甲文拉法辛Target: 5-HT Transporters|Norepinephrine transportersSummary: 5-羟色胺（5-HT）和去甲肾上腺素（NE）再摄取抑制剂